Senior insider sale
Chief Business Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$1.31M
16.64K shares
What this filing means
BAROLDI JOSEPH plans to sell 16.64K shares of IONIS PHARMACEUTICALS INC valued at approximately $1.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/28/2026ACC: 0001972481-26-000138
Officer· Chief Business Officer
Since Jan 2022
16.64K
Shares to sell
$1.31M
Approx. market value
10.84K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Equity Compensation
4/15/2022
10.84KTotal acquired10.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/15/2022 | Restricted Stock Equity Compensation | 10.84K | — |
| Total | 10.84K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5.62K
Market value
$423.7K
4/16/2026
—Completed
Units to sell
4.10K
Market value
$325.1K
3/3/2026
—Completed
Units to sell
5.30K
Market value
$439.7K
1/30/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.63K
Market value
$116.7K
4/28/2026
Total
Units
16.64K
Value
$1.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 5.62K | $423.7K | — | Completed |
3/3/2026 | 4.10K | $325.1K | — | Completed |
1/30/2026 | 5.30K | $439.7K | — | Completed |
| Planned — Approximate Date | ||||
4/28/2026 | 1.63K | $116.7K | Nasdaq | Planned |
| Total | 16.64K | $1.31M | ||